Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial
一项针对成人的二价(D614 + B.1.351)SARS-CoV-2重组蛋白疫苗联合AS03佐剂的疗效研究:一项3期平行、随机、改良双盲、安慰剂对照试验
期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(23)00263-1
Dayan, Gustavo H; Rouphael, Nadine; Walsh, Stephen R; Chen, Aiying; Grunenberg, Nicole; Allen, Mary; Antony, Johannes; Asante, Kwaku Poku; Bhate, Amit Suresh; Beresnev, Tatiana; Bonaparte, Matthew I; Celle, Médéric; Ceregido, Maria Angeles; Corey, Lawrence; Dobrianskyi, Dmytro; Fu, Bo; Grillet, Marie-Helene; Keshtkar-Jahromi, Maryam; Juraska, Michal; Kee, Jia Jin; Kibuuka, Hannah; Koutsoukos, Marguerite; Masotti, Roger; Michael, Nelson L; Neuzil, Kathleen M; Reynales, Humberto; Robb, Merlin L; Villagómez Martínez, Sandra M; Sawe, Fredrick; Schuerman, Lode; Tong, Tina; Treanor, John; Wartel, T Anh; Diazgranados, Carlos A; Chicz, Roman M; Gurunathan, Sanjay; Savarino, Stephen; Sridhar, Saranya